Windtree Therapeutics Inc
WINT
Get informed when a big investor buys or sells
+ FollowMarket Cap$337.09K
Close$
$-0.82
5941.4% downside
Current Fair Value
5941.4% downsideOvervalued by 5941.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $337,088.00 |
|---|---|
| Enterprise Value | $3.51 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-104.35 |
| Beta | 1.76 |
| Outstanding Shares | 26,675 |
Return
| Return on Equity | -506155.56% |
|---|---|
| Return on Assets | -285.02% |
| Return on Invested Capital | 128.91% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.01 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 77.94 |
| Enterprise Value to EBIT | -0.46 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.96 |
| Debt to Equity | 374.89 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Windtree Therapeutics Inc
31 employeesWindtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset franc...